Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

Laziz Turaev

9 ta ish

Ўзбекистон Республикаси Соғлиқни сақлаш вазирлиги

AkademScholarda batafsil koʻrsatkichlar

  1. Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011

    Dilrabo Ulmasova, G Uzakova, M N Tillyashayhov +17

    MaqolaOchiq kirishTuberculosis Research and EpidemiologyEurosurveillance201315 iqtibos
    ABI

  2. Scaling Up Molecular Diagnostic Tests for Drug-Resistant Tuberculosis in Uzbekistan from 2012–2019: Are We on the Right Track?

    Sharofiddin Yuldashev, Nargiza Parpieva, Salikhdjan Alimov +6

    MaqolaOchiq kirishTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20213 iqtibos
    ABI

  3. Direct comparison of GeneXpert MTB/RIF (Cepheid) with probeTEC (Becton-Dickinson) and Taqman MTB (Roche) for detection of TB bacteria

    Harald Hoffmann, Sabine Hofmann-Thiel, Laziz Turaev +4

    MaqolaPneumonia and Respiratory InfectionsPneumologie20120 iqtibos
    ABI

  4. Evaluation of the new, easy to perform, IS6110 based molecular assay Speed-oligo® Direct MTB (Vircell, Spain) for the detection of M. tuberculosis and direct comparison to probeTec (BD, USA)

    Uladzimir Antonenka, Sabine Hofmann-Thiel, A Esenalieva +4

    MaqolaTuberculosis Research and EpidemiologyPneumologie20120 iqtibos
    ABI

  5. Comparison of Xpert MTB/RIF with ProbeTec ET DTB and COBAS TaqMan MTB for direct detection of M. tuberculosis complex in respiratory specimens

    Uladzimir Antonenka, Sabine Hofmann-Thiel, Laziz Turaev +5

    MaqolaOchiq kirishTuberculosis Research and EpidemiologyBMC Infectious Diseases20130 iqtibos
    ABI

  6. Treatment Outcomes of Isoniazid-Resistant (Rifampicin Susceptible) Tuberculosis Patients in Uzbekistan, 2017–2018

    Zayniddin Sayfutdinov, Ajay Kumar, Dilyara Nabirova +5

    MaqolaOchiq kirishTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20210 iqtibos
    ABI

  7. Universal Access to Xpert MTB/RIF Testing for Diagnosis of Tuberculosis in Uzbekistan: How Well Are We Doing?

    Laziz Turaev, Ajay Kumar, Dilyara Nabirova +3

    MaqolaOchiq kirishTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20210 iqtibos
    ABI

  8. Is Xpert MTB/Rif Ultra superior to Xpert MTB/Rif for the diagnosis of tuberculosis in children in Uzbekistan

    Sanjar Sultanov, Nargiza Parpieva, Kozim Mukhamedov +3

    MaqolaIdeological and Political Education20210 iqtibos
    ABI

  9. Tuberculosis diagnosis and the complete drug resistance pattern from a single sample within a single day by use of a composite platform of MAX MDR-TB and AmPORE-TB

    Harald Hoffmann, Andrey Golubov, Caroline S. Corbett +8

    MaqolaOchiq kirish20260 iqtibos
    ABI